Opis Research
Private Company
Funding information not available
Overview
Opis Research is a private, Milan-based clinical CRO offering end-to-end clinical development services from study design through to data analysis and reporting. Founded in 2015, it has established itself as a specialized partner for complex trials in oncology, hematology, CNS, rare diseases, and advanced therapies, supported by a proprietary EDC system, Clinical.net. The company is revenue-generating, operates with a flexible business model, and maintains key quality certifications (ISO 9001, ISO 27001, FDA 21 CFR Part 11 compliant), serving pharmaceutical, biotech, and medical device clients globally.
Technology Platform
Proprietary electronic data capture (EDC) and clinical trial management system called Clinical.net, a fully customizable modular framework developed in-house. Supported by ISO 9001, ISO 27001, and FDA 21 CFR Part 11 compliant systems.
Opportunities
Risk Factors
Competitive Landscape
Operates in the highly fragmented and competitive global CRO market. Competes with large, full-service multinationals (e.g., IQVIA, ICON, Parexel, PPD) for major contracts, and with numerous small-to-mid-sized regional and specialty CROs. Differentiation is based on therapeutic expertise (CNS, Oncology), proprietary technology (Clinical.net), and a quality-focused, flexible service model.